Ingredion Incorporated $INGR Shares Purchased by Brandes Investment Partners LP

Brandes Investment Partners LP increased its stake in Ingredion Incorporated (NYSE:INGR) by 26.2% in the fourth quarter, HoldingsChannel.com reports. The firm owned 403,503 shares of the company’s stock after acquiring an additional 83,855 shares during the quarter. Brandes Investment Partners LP’s holdings in Ingredion were worth $44,491,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. International Assets Investment Management LLC purchased a new position in shares of Ingredion in the 4th quarter valued at about $30,000. Los Angeles Capital Management LLC purchased a new position in Ingredion in the fourth quarter valued at about $36,000. Capital Advisors Ltd. LLC increased its holdings in Ingredion by 40.5% in the fourth quarter. Capital Advisors Ltd. LLC now owns 354 shares of the company’s stock valued at $39,000 after buying an additional 102 shares in the last quarter. Caitong International Asset Management Co. Ltd increased its holdings in Ingredion by 166.4% in the third quarter. Caitong International Asset Management Co. Ltd now owns 381 shares of the company’s stock valued at $47,000 after buying an additional 238 shares in the last quarter. Finally, Ares Financial Consulting LLC purchased a new position in Ingredion in the fourth quarter valued at about $46,000. Hedge funds and other institutional investors own 85.27% of the company’s stock.

Ingredion Trading Up 1.8%

Shares of INGR opened at $101.49 on Wednesday. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.76 and a quick ratio of 1.83. The firm has a 50 day simple moving average of $107.90 and a 200-day simple moving average of $111.26. Ingredion Incorporated has a 1-year low of $97.12 and a 1-year high of $140.47. The stock has a market cap of $6.40 billion, a price-to-earnings ratio of 9.78, a price-to-earnings-growth ratio of 0.83 and a beta of 0.60.

Ingredion (NYSE:INGR) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $2.34 earnings per share for the quarter, missing analysts’ consensus estimates of $2.44 by ($0.10). Ingredion had a return on equity of 15.86% and a net margin of 9.36%.The business had revenue of $1.79 billion for the quarter, compared to analysts’ expectations of $1.79 billion. During the same period last year, the business earned $2.97 earnings per share. The company’s revenue for the quarter was down 1.2% on a year-over-year basis. Ingredion has set its FY 2026 guidance at 10.450-11.150 EPS. Equities analysts forecast that Ingredion Incorporated will post 10.88 EPS for the current fiscal year.

Ingredion Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 21st. Stockholders of record on Wednesday, July 1st will be paid a dividend of $0.82 per share. This represents a $3.28 dividend on an annualized basis and a dividend yield of 3.2%. The ex-dividend date of this dividend is Wednesday, July 1st. Ingredion’s dividend payout ratio (DPR) is 31.60%.

Key Stories Impacting Ingredion

Here are the key news stories impacting Ingredion this week:

• Positive Sentiment: Ingredion announced a recommended all-cash acquisition of Tate & Lyle, a move that could expand its specialty-ingredients business and improve long-term growth opportunities. Ingredion Announces Recommended All-Cash Acquisition of Tate & Lyle
• Neutral Sentiment: Analysts are reporting mixed views on Ingredion, suggesting investors are still weighing the benefits of the deal against execution and integration risk. Analysts’ Opinions Are Mixed on These Consumer Goods Stocks: Ingredion (INGR) and Walmart (WMT)
• Negative Sentiment: One analyst downgraded Ingredion, which may reflect caution around valuation, leverage, or the near-term impact of the acquisition. This Ingredion Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday

Insider Buying and Selling at Ingredion

In other news, VP Davida Marie Gable sold 375 shares of the firm’s stock in a transaction that occurred on Wednesday, March 18th. The shares were sold at an average price of $112.44, for a total transaction of $42,165.00. Following the completion of the transaction, the vice president directly owned 7,110 shares of the company’s stock, valued at $799,448.40. This trade represents a 5.01% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.60% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on INGR shares. Benchmark reaffirmed a “buy” rating on shares of Ingredion in a report on Tuesday. Barclays dropped their target price on shares of Ingredion from $128.00 to $120.00 and set an “equal weight” rating for the company in a report on Wednesday, May 6th. Oppenheimer cut shares of Ingredion from an “outperform” rating to a “market perform” rating in a report on Monday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Ingredion in a report on Friday, March 27th. Finally, UBS Group reaffirmed a “neutral” rating and issued a $114.00 target price on shares of Ingredion in a report on Thursday, May 7th. One equities research analyst has rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Ingredion currently has a consensus rating of “Hold” and an average target price of $122.43.

Ingredion Profile

Ingredion Incorporated is a global ingredient solutions company specializing in the production and sale of starches, sweeteners, nutrition ingredients and biomaterials derived primarily from corn and other plant-based raw materials. The company serves a diverse set of industries, including food and beverage, brewing, pharmaceuticals and personal care, providing functional ingredients that enhance texture, stability, flavor and nutritional value in a wide array of end products.

The company’s product portfolio comprises native and modified starches, high-fructose corn syrup, dextrose, maltodextrins, specialty sweeteners and various texturizers.